Literature DB >> 15212762

Expression of NALP1 in cerebellar granule neurons stimulates apoptosis.

Feng Liu1, C Frederick Lo, Xiaoping Ning, Eileen M Kajkowski, Mei Jin, Camelia Chiriac, Cathleen Gonzales, Saule Naureckiene, Yeung-Wai Lock, Kevin Pong, Margaret M Zaleska, J Steven Jacobsen, Sanford Silverman, Bradley A Ozenberger.   

Abstract

NAcht Leucine-rich-repeat Protein 1 (NALP1) contains a putative nucleotide binding site, a region of leucine-rich repeats, and death domain folds at both termini providing protein/protein association functions such as caspase recruitment. We report here that NALP1 gene expression was induced in primary cerebellar granule neurons (CGN) upon injury. Up-regulation of NALP1 was also observed in a model of transient focal ischemia induced by middle cerebral artery occlusion. We investigated the biological consequence of over-expression of NALP1 in both HeLa cells and in CGN. Expression of recombinant NALP1 stimulated cell death in both HeLa cells and CGN by an apoptotic mechanism, demonstrated by the induction of apoptotic nuclear morphology and activation of the apoptotic enzyme caspase-3. Also described here are studies on the mechanism of action studies including deletion analyses and investigations of nucleotide binding, which begin to elucidate a regulatory function for NALP1 in neuronal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212762     DOI: 10.1016/j.cellsig.2004.02.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  17 in total

Review 1.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 2.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 3.  NLRs in immune privileged sites.

Authors:  Holly L Rosenzweig; Stephen R Planck; James T Rosenbaum
Journal:  Curr Opin Pharmacol       Date:  2011-07-29       Impact factor: 5.547

4.  Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose.

Authors:  Xian-Fang Meng; Xiao-Lan Wang; Xiu-Juan Tian; Zhi-Hua Yang; Guang-Pin Chu; Jing Zhang; Man Li; Jing Shi; Chun Zhang
Journal:  Mol Neurobiol       Date:  2013-09-08       Impact factor: 5.590

Review 5.  Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways.

Authors:  George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-17       Impact factor: 6.200

6.  Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.

Authors:  David Yang-Wei Fann; Yun-An Lim; Yi-Lin Cheng; Ker-Zhing Lok; Prasad Chunduri; Sang-Ha Baik; Grant R Drummond; S Thameem Dheen; Christopher G Sobey; Dong-Gyu Jo; Christopher Li-Hsian Chen; Thiruma V Arumugam
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

7.  Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.

Authors:  V Kaushal; R Dye; P Pakavathkumar; B Foveau; J Flores; B Hyman; B Ghetti; B H Koller; A C LeBlanc
Journal:  Cell Death Differ       Date:  2015-03-06       Impact factor: 15.828

Review 8.  NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications.

Authors:  Shalini Singh; Sushmita Jha
Journal:  Mol Neurobiol       Date:  2018-03-06       Impact factor: 5.590

9.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

Review 10.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.